A valuation of infusion therapy to preserve islet function in type 1 diabetes.

Lloyd, Andrew; Swinburn, Paul; Boye, Kristina S; Curtis, Bradley; Sarpong, Eric; Goldsmith, Kim; Bode, Bruce; Aronoff, Stephen

Lloyd, Andrew; Swinburn, Paul; Boye, Kristina S; Curtis, Bradley; Sarpong, Eric; Goldsmith, Kim; Bode, Bruce; Aronoff, Stephen.

Affiliation

Lloyd A; Oxford Outcomes Ltd, Oxford, UK. andrew.lloyd@oxfordoutcomes.com

Value Health ; 13(5): 636-42, 2010 Aug.

Article in En | MEDLINE | ID: mdl-20712603

Subject(s)

Diabetes Mellitus, Type 1/drug therapy; Diabetes Mellitus, Type 1/psychology; Infusion Pumps; Insulin-Secreting Cells/drug effects; Quality of Life/psychology; Adaptation, Psychological; Adolescent; Adult; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal/therapeutic use; Child; Confidence Intervals; Decision Making; Diabetes Mellitus, Type 1/immunology; Female; Health Status Indicators; Health Surveys; Humans; Hypoglycemic Agents/administration & dosage; Insulin/administration & dosage; Insulin-Secreting Cells/physiology; Male; Multivariate Analysis; Pilot Projects; Psychometrics; Qualitative Research; Quality-Adjusted Life Years; Surveys and Questionnaires

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Infusion Pumps / Diabetes Mellitus, Type 1 / Insulin-Secreting Cells Type of study: Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2010 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google